NASDAQ:FTXH First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News → AI Bubble Now at Critical Mass (From Porter & Company) (Ad) Free FTXH Stock Alerts $28.09 +0.07 (+0.25%) (As of 11:00 AM ET) Add Compare Share Share Today's Range$28.00▼$28.0950-Day Range$26.96▼$28.3452-Week Range$23.85▼$28.41Volume665 shsAverage Volume7,629 shsMarket Capitalization$21.07 millionAssets Under Management$20.99 millionDividend Yield1.71%Net Expense Ratio0.60% Stock AnalysisStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get First Trust Nasdaq Pharmaceuticals ETF alerts: Email Address About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Read More FTXH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTXH ETF News HeadlinesAugust 3, 2022 | stocknews.com3 Health Care ETFs You'll Want to Own When the Market RecoversMay 25, 2022 | nasdaq.comSurprising Analyst 12-Month Target For FTXHMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 25, 2022 | seekingalpha.comFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488February 22, 2022 | nasdaq.comSolid Q4 Earnings Fail to Impress Pharma ETFsNovember 9, 2021 | nasdaq.comWave of Solid Q3 Earnings Push Pharma ETFs HigherAugust 19, 2021 | msn.com4 ETF Strategies to Follow Warren Buffett's VisionSee More Headlines Receive FTXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFirst Trust Fund NameFirst Trust Nasdaq Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FTXH Inception Date9/20/2016 Fund ManagerDaniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkNasdaq US Smart Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings51 Fund Statistics Assets Under Management$20.99 million Average Daily Volume$6,197.40 Discount/Premium0.04% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest1,000 shs Miscellaneous Outstanding Shares750,000Beta0.70 Creation Unit50,000 Creation Fee$500.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… First Trust Nasdaq Pharmaceuticals ETF ExpensesTypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.57%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.32%0.58%Total Expense0.60%0.72%0.70%0.57%0.70%Fee Waiver0.00%-0.53%-0.54%-0.20%-0.56%Net Expense0.60%0.61%0.60%0.54%0.58% First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & ExposureTop 10 FTXH HoldingsJohnson & Johnson(NYSE:JNJ)Holding Weight: 8.15%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 7.23%AbbVie(NYSE:ABBV)Holding Weight: 7.02%Pfizer(NYSE:PFE)Holding Weight: 6.34%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 6.30%Eli Lilly and Company(NYSE:LLY)Holding Weight: 6.05%Cardinal Health(NYSE:CAH)Holding Weight: 4.37%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 4.28%Zoetis(NYSE:ZTS)Holding Weight: 4.09%Amgen(NASDAQ:AMGN)Holding Weight: 4.06%FTXH Sector ExposureFTXH Industry ExposureFull Holdings Details Similar ETFsHorizon Kinetics Medical ETFNASDAQ:MEDXInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISPrincipal Healthcare Innovators ETFNASDAQ:BTECInstitutional OwnershipGoldman Sachs Group Inc.Bought 26,703 shares on 3/1/2024Ownership: 8.292%Citadel Advisors LLCBought 7,963 shares on 2/15/2024Ownership: 1.062%OLD Mission Capital LLCBought 7,907 shares on 2/15/2024Ownership: 1.054%Goldman Sachs Group Inc.Bought 26,703 shares on 2/13/2024Ownership: 8.292%Steward Partners Investment Advisory LLCSold 1,703 shares on 2/12/2024Ownership: 7.329%View All Institutional Transactions FTXH ETF - Frequently Asked Questions How have FTXH shares performed in 2024? First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 at the beginning of 2024. Since then, FTXH shares have increased by 5.5% and is now trading at $28.09. View the best growth stocks for 2024 here. How often does First Trust Nasdaq Pharmaceuticals ETF pay dividends? What is the dividend yield for First Trust Nasdaq Pharmaceuticals ETF? First Trust Nasdaq Pharmaceuticals ETF announced a dividend on Wednesday, March 20th. Shareholders of record on Friday, March 22nd will be given a dividend of $0.0676 per share on Thursday, March 28th. The ex-dividend date of this dividend is Thursday, March 21st. Read our dividend analysis for FTXH. What does FTXH invest in? First Trust Nasdaq Pharmaceuticals ETF is a equity fund issued by First Trust. FTXH focuses on health care investments and follows the Nasdaq US Smart Pharmaceuticals Index. The fund's investments total to approximately $20.99 million assets under management. What stocks does First Trust Nasdaq Pharmaceuticals ETF hold? FTXH invests in 51 holdings. Some of the stocks in their portfolio include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie (ABBV), Pfizer (PFE), Bristol-Myers Squibb (BMY), Eli Lilly and Company (LLY), Cardinal Health (CAH), Vertex Pharmaceuticals (VRTX), Zoetis (ZTS) and Amgen (AMGN). What is the management fee for First Trust Nasdaq Pharmaceuticals ETF? First Trust Nasdaq Pharmaceuticals ETF's management fee is 0.60% and has no other recorded expenses or fee waivers. The net expense ratio for FTXH is 0.60%. What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC), BioCorRx (BICX), BlackRock Municipal Income Trust (BFK), AmeriGas Partners (APU) and Aphria (APHA). Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders? First Trust Nasdaq Pharmaceuticals ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include International Assets Investment Management LLC (10.26%), International Assets Investment Management LLC (10.26%), Goldman Sachs Group Inc. (8.29%), Goldman Sachs Group Inc. (8.29%), Steward Partners Investment Advisory LLC (7.33%) and Outlook Wealth Advisors LLC (1.15%). How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF? Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTXH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.